Department of Biological Sciences, University of Cyprus, Aglantzia, Nicosia, Cyprus.
Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Goudi, Athens, Greece.
PLoS One. 2018 Apr 23;13(4):e0195660. doi: 10.1371/journal.pone.0195660. eCollection 2018.
A molecular epidemiology study of HIV-1 infection was conducted in one hundred diagnosed and untreated HIV-1-infected patients in Cyprus between 2010 and 2012, representing 65.4% of all the reported HIV-1 infections in Cyprus in this three-year period, using a previously defined enrolment strategy. Eighty-two patients were newly diagnosed (genotypic drug resistance testing within six months from diagnosis), and eighteen patients were HIV-1 diagnosed for a longer period or the diagnosis date was unknown. Phylogenetic trees of the pol sequences obtained in this study with reference sequences indicated that subtypes B and A1 were the most common subtypes present and accounted for 41.0 and 19.0% respectively, followed by subtype C (7.0%), F1 (8.0%), CRF02_AG (4.0%), A2 (2.0%), other circulating recombinant forms (CRFs) (7.0%) and unknown recombinant forms (URFs) (12%). Most of the newly-diagnosed study subjects were Cypriots (63%), males (78%) with median age 39 (Interquartile Range, IQR 33-48) reporting having sex with other men (MSM) (51%). A high rate of clustered transmission of subtype B drug-sensitive strains to reverse transcriptase and protease inhibitors was observed among MSM, twenty-eight out of forty-one MSM study subjects (68.0%) infected were implicated in five transmission clusters, two of which are sub-subtype A1 and three of which are subtype B strains. The two largest MSM subtype B clusters included nine and eight Cypriot men, respectively, living in all major cities in Cyprus. There were only three newly diagnosed patients with transmitted drug resistant HIV-1 strains, one study subject from the United Kingdom infected with subtype B strain and one from Romania with sub-subtype A2 strain, both with PI drug resistance mutation M46L and one from Greece with sub-subtype A1 with non-nucleoside reverse transcriptase inhibitors (NNRTI) drug resistance mutation K103N.
在 2010 年至 2012 年期间,对塞浦路斯的 100 名确诊且未经治疗的 HIV-1 感染者进行了 HIV-1 感染的分子流行病学研究,这代表了在这三年期间塞浦路斯报告的所有 HIV-1 感染病例的 65.4%。使用了先前定义的纳入策略。82 名患者为新诊断患者(从诊断之日起六个月内进行基因型耐药性测试),18 名患者为 HIV-1 诊断时间较长或诊断日期未知的患者。从本研究中获得的 pol 序列与参考序列构建的系统进化树表明,B 和 A1 亚型是最常见的亚型,分别占 41.0%和 19.0%,其次是 C 亚型(7.0%)、F1(8.0%)、CRF02_AG(4.0%)、A2(2.0%)、其他循环重组形式(CRFs)(7.0%)和未知重组形式(URFs)(12%)。大多数新诊断的研究对象为塞浦路斯人(63%),男性(78%),中位年龄 39 岁(四分位距 IQR 33-48),报告有与其他男性(MSM)发生性行为(51%)。在 MSM 中观察到 B 亚型对逆转录酶和蛋白酶抑制剂敏感的耐药株的高度聚集性传播,41 名 MSM 研究对象中有 28 人(68.0%)感染的五组传播集群中,其中两个为亚亚型 A1,三个为 B 亚型。最大的两个 MSM B 亚型集群分别包括 9 名和 8 名塞浦路斯男性,分别居住在塞浦路斯的所有主要城市。仅有 3 名新诊断的患者感染了传播耐药性 HIV-1 株,1 名来自英国的研究对象感染了 B 亚型株,1 名来自罗马尼亚的研究对象感染了 A2 亚型株,两者均具有蛋白酶抑制剂耐药性突变 M46L,1 名来自希腊的研究对象感染了 A1 亚型株,具有非核苷类逆转录酶抑制剂(NNRTI)耐药性突变 K103N。